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INTRODUCTION
Cardiomyocyte necrosis triggers an intense inflammatory cascade that serves to clear the injured myocardium of dead cells and sets the stage for activation of the reparative process. In myocardial infarction, necrotic cardiomyocytes release alarmins, activating innate immune signals and inducing recruitment of proinflammatory leukocytes. Although inflammation is required for phagocytotic removal of dead cells and for activation of reparative mesenchymal cells, timely suppression and spatial containment of the inflammatory reaction are necessary to prevent extension of injury. Overactive, dysregulated, temporally prolonged or spatially expanded inflammatory responses may cause death of viable cardiomyocytes, enhance matrix degradation (thus promoting dilative remodeling), and extend fibrosis [1] . The inflammatory cascade in myocardial infarction and heart failure is an attractive therapeutic target; however, implementation of antiinflammatory strategies is challenging because of the pleiotropic and multifunctional effects of inflammatory mediators that may activate both injurious and reparative processes. Thus, dissection of the inflammatory signals implicated in cardiac injury and repair, and identification of the effector cells involved in regulation of inflammation, is of outstanding significance. This article will present recent advances that significantly contributed to our understanding of myocardial inflammation.
ACTIVATION OF PROINFLAMMATORY CASCADES FOLLOWING CARDIAC INJURY: THE 'DANGER SIGNALS'
Necrotic cardiomyocytes are capable of releasing a wide range of damage-associated molecular patterns that activate innate immune pathways, triggering the inflammatory response ( Fig. 1 ) [2] . Although high-mobility group box-1 has been suggested as an important cardiomyocyte-derived alarmin [3, 4] , the identity of the key primary stimulus that may trigger the inflammatory reaction following infarction remains unknown. Using a combination of in-vivo and in-vitro approaches, Lugrin et al. [5 & ] demonstrated that necrotic cardiomyocytes release interleukin-1a, a key early damage signal that activates the abundant fibroblasts in the myocardium, promoting their proinflammatory activation through MyD88-dependent, toll like receptor (TLR)-independent signaling ( Fig. 1 ). Interleukin-1 signaling is critically implicated in activation of the postinfarction inflammatory response: in addition to interleukin-1a released by necrotic cells, de-novo synthesis and activation of interleukin-1b stimulate type 1 interleukin-1 receptor signaling in proinflammatory leukocytes and in fibroblasts [6] . In both leukocytes and fibroblasts, activation of interleukin-1 signaling induces cytokine expression and promotes matrix-degrading properties [7] . Moreover, interleukin-1 suppresses fibroblast proliferation [8] and inhibits transdifferentiation of fibroblasts into myofibroblasts [7, 9] , delaying activation of a reparative response until the infarct is cleared of dead cells and matrix debris. Interleukin-1a is not the only endogenous danger signal released by cardiomyocytes in the infarcted region. Chen et al. [10] identified release of RNA (including several mRNAs) by necrotic cardiomyocytes as an important injury-activated proinflammatory stimulus in the infarcted heart. Extracellular RNA contributed to myocardial inflammation by activating a TLR-3/ Toll/interleukin-1 receptor domain-containing adaptor inducing interferon-b (Trif) cascade. In the pressure overloaded heart, mitochondrial DNA that escapes from autophagy has been reported to trigger TLR-9-dependent inflammation, extending myocardial injury [11] . Whether a similar proinflammatory pathway is activated in the infarcted heart remains unknown. The cellular targets of these danger signals include cardiomyocytes, vascular cells, fibroblasts and infiltrating leukocytes [12] . Whether specific alarmins activate distinct cell types driving injurious or reparative functions remains unknown. A growing body of evidence suggests that activation of innate immune signaling in hematopoietic cells may exert deleterious actions, extending injury. Bone marrow transplantation experiments in mice suggested that activation of TLR2, or stimulation of complement-activated responses in leukocytes, extends ischemic injury [13, 14] .
KEY POINTS
Necrotic cardiomyocytes release danger signals that activate innate immune pathways and may extend injury, but also serve a crucial role in clearance of dead cells and in cardiac repair.
Lymphocyte subpopulations play an important role in negative regulation of the postinfarction inflammatory response.
Macrophage subsets orchestrate reparative responses following cardiac injury.
Neonatal resident cardiac macrophages may promote cardiac regeneration. 
REMOVAL OF APOPTOTIC CELLS AS A MECHANISM FOR SUPPRESSION OF POSTINFARCTION INFLAMMATION
Repair of injured tissues is dependent on timely suppression and resolution of proinflammatory signaling. In the healing infarct, negative regulation of the inflammatory response is critical for protection of the infarcted heart from adverse remodeling. Clearance of dead cells by phagocytes activates an inhibitory program, serving as a key mechanism for termination of the proinflammatory cascade. Wan et al. [15 && ] provided the first demonstration of a critical role for cardiomyocyte efferocytosis (the process by which dying cells are removed by phagocytes) in suppression of acute inflammation following myocardial infarction. Induction of macrophage myeloid-epithelial-reproductive tyrosine kinase in myocardial phagocytes was necessary for effective engulfment and removal of apoptotic cardiomyocytes from the infarct. Disruption of cardiomyocyte efferocytosis resulted in prolonged inflammation and accentuated adverse remodeling. Whether clearance of other apoptotic cell types involves distinct pathways remains unknown. In the healing infarct, the majority of apoptotic cells are noncardiomyocytes; infiltrating neutrophils represent a large pool of cells programed to undergo apoptosis. Their clearance from the infarcted heart may also activate an inhibitory program leading to resolution of inflammation.
LYMPHOCYTE SUBPOPULATIONS: KEY EFFECTOR CELLS IMPLICATED IN NEGATIVE REGULATION OF INFLAMMATION
Although descriptive studies in large animal models have demonstrated that the infarcted hearts recruit lymphocytes expressing antiinflammatory cytokines (such as interleukin-10) [16] , the critical role of lymphocyte subpopulations in regulation of the inflammatory and reparative response has only recently been appreciated. Zouggari et al. [17 & ] demonstrated that B cells produce the CC chemokine CCL7 and mobilize proinflammatory monocytes in mouse infarcts, increasing cardiomyocyte injury. During the reparative phase, lymphocyte subsets with inhibitory properties, such as regulatory T cells (Tregs), are recruited in the infarct through pathways that may involve distinct chemokine/chemokine receptor pairs [18] . Recent studies using both genetic and antibody-mediated depletion strategies have suggested a critical role for Tregs in suppression of the inflammatory reaction following myocardial infarction [19] . Tregs may act by promoting differentiation of macrophages to an antiinflammatory phenotype [19] and by modulating protease synthesis by cardiac fibroblasts [20] . The protective actions of Tregs may involve both secreted mediators and contact-dependent cell-cell interactions [21] . Selective activation of invariant natural killer T cells through administration of a-galactosylceramide also suppressed inflammation and attenuated injury in experimental models of myocardial infarction [22, 23] . These studies suggest that, despite their small numbers [20, 24] , infiltrating T cell subpopulations are capable of exerting profound effects on many other cell types involved in cardiac inflammation, repair and remodeling (Fig. 2) .
ARE SURVIVING CARDIOMYOCYTES A SOURCE OF PROTECTIVE CYTOKINES IN THE HEALING INFARCT?
In the early hours after infarction, necrotic cardiomyocytes release danger signals that initiate inflammation and may extend injury. However, spatial containment of the inflammatory response into the area of infarction is critical for optimal repair, and may be dependent on activation of inhibitory pathways in the border zone [25, 26] . Do viable cardiomyocytes in the infarct border zone secrete cytoprotective and antiinflammatory mediators that may serve as a protective 'barrier' preventing expansion of the inflammatory response? A recent study by Rainer et al. [27 & ] suggests that cardiomyocytes may secrete a wide range of cytoprotective mediators; expression of these signals may be regulated by the local cytokine environment. Mice with cardiomyocyte-specific loss of transforming growth factor-b signaling were protected against rupture through an increase in levels of protective mediators, such as interleukin-33, thrombospondin-4 and growth differentiation factor-15. The findings highlight the pleiotropic actions of transforming growth factor-b, suggesting that in addition to its effects on leukocytes, fibroblasts and vascular cells [28] , it may also inhibit activation of a protective program in cardiomyocytes of the infarct border zone.
THE CARDIAC MACROPHAGES
Despite their abundance in the infarcted heart, macrophages have remained understudied, in part because of their functional heterogeneity [29 & ]. Over the last 2 years, several high-impact investigations have shed new light on the role of macrophages in cardiac homeostasis, injury and repair. The adult mouse heart contains a heterogeneous population of macrophages that can be subclassified into several subsets with distinct ontological origins [30,31 && ]. The cardiac macrophage population is derived from yolk-sac macrophages and from fetal monocyte progenitors and is maintained through local proliferation. As mice age, these resident macrophages are progressively replaced by monocyte-derived cells, even in the absence of inflammatory stimulation [32] . Following infarction, the heart is infiltrated by abundant macrophages; the majority of these newly recruited cells are derived from circulating Ly-6C(high) monocytes attracted in the healing infarct through interactions involving the CC chemokine monocyte chemoattractant protein-1/CCL2 [33,34,35 & ]. Infiltrating monocytes may be derived not only from the bone marrow, but also from the spleen [36, 37] . Expression of the transcription factor interferon regulatory factor 5 is increased in macrophages during the inflammatory phase of cardiac repair and drives a proinflammatory program [38] . As the infarct heals, reparative Ly-6C(low) F4/80 (high) macrophages, derived from the Ly-6C(high) monocyte subpopulation, proliferate and express inhibitory mediators, promoting repair [34] . If the majority of infarct macrophages are derived from monocytes, what is the fate of the resident cardiac macrophage subpopulations? Much like for other populations of interstitial cells, the susceptibility of macrophages to ischemic injury remains unknown. Evidence suggests that some resident macrophages may undergo apoptosis following permanent coronary occlusion [35 & ]. Whether there is complete removal and replacement of the original resident macrophage population remains unknown.
DO MACROPHAGES HOLD THE KEY TO CARDIAC REGENERATION?
Recent experimental evidence suggests that macrophages may be critically involved in cardiac repair and regeneration. In an apical resection model, neonatal mice exhibited myocardial regeneration; this capacity was lost at 7 days of age [39] . Depletion of macrophages abrogated regeneration of the neonatal heart, suggesting that neonatal cardiac macrophages exhibit a unique regenerative phenotype and secrete soluble mediators that contribute to formation of new myocardium [40 && ]. Similar observations were noted in a model of genetic cardiomyocyte ablation driven by a diphtheria toxin receptor-based system. In neonatal mice, cardiomyocyte ablation resulted in expansion of embryonic-derived resident macrophages that promoted cardiomyocyte proliferation. In contrast, in adult hearts, recruitment of proinflammatory monocytes inhibited repair. These findings suggested that embryonic resident macrophage populations may be essential cellular effectors in cardiac regeneration [41 & ].
Although the emerging body of evidence suggesting a potential role of macrophage subsets in cardiac regeneration is of outstanding interest, caution is advised regarding interpretation of the findings. First, the observations on regeneration of the neonatal heart are predominantly derived from experimental models with a disease that is quite different from infarction of ischemic origin. In the apical resection model, removal of cardiac tissue eliminates the main source of 'danger signals' responsible for activation of inflammation in infarctive cardiac injury. Myocardial regeneration may be much more complicated in an environment that contains abundant dying cells and fragmented matrix proteins. On the other hand, in the cardiomyocyte ablation model, preservation of vascular and interstitial cells, and possible differences in the mechanism of cardiomyocyte death, may result in distinct reparative responses that do not recapitulate repair of ischemic infarction. Second, to what extent the observations made in neonatal mice can be generalized in higher mammals, and in particular in humans, is unknown. The profile and properties of macrophages in human hearts have not been systematically investigated. Moreover, whether human neonatal macrophages exhibit reparative and regenerative properties has not been tested. 
CLINICAL IMPLICATIONS
The negative experience with implementation of early antiinflammatory strategies in myocardial infarction [42] and the complex effects of inflammatory pathways in injury and repair have discouraged attempts to target inflammation in heart disease. In patients with overactive, or dysregulated, postinfarction inflammatory responses, inhibition of inflammation may be a promising strategy to attenuate adverse remodeling. Antiinterleukin-1 approaches are particularly attractive and have already been tested in pilot studies with promising results. Treatment of patients with ST elevation myocardial infarction with recombinant interleukin-1 receptor antagonist attenuated adverse remodeling [43] and reduced the incidence of heart failure [44] . Approaches targeting the monocyte chemoattractant protein (MCP)-1/C-C chemokine receptor (CCR2) system may selectively inhibit proinflammatory monocytes, preventing adverse remodeling [45] . Identification of patients with excessive postinfarction inflammation using suitable biomarkers, or imaging approaches, may be needed for optimal selection of patients likely to benefit from antiinflammatory strategies [46] . Expansion of our understanding of the immune cell subsets that promote cardiac regeneration may lead to identification of new cell therapy approaches to generate new myocardium.
CONCLUSION
Cardiomyocyte death activates resident myocardial populations that serve to sense injury and to repair the damaged heart. These noncardiomyocyte populations exhibit remarkable plasticity and undergo dynamic changes in the environment of the infarct. Moreover, danger signals released by dying cells recruit leukocyte subsets that play a critical role in clearance of the wound and in activation of a reparative program. Studies published over the last 12 months suggested that unique subpopulations of macrophages may be capable of inducing myocardial regeneration, implying that the inflammatory reaction to myocardial injury can be modulated toward a regenerative path. A lot remains to be learned regarding these leukocyte subsets, the basis for their reparative properties, and the pathways driving their differentiation. However, these observations stress the importance of the noncardiomyocyte compartment in determining the fate of cardiomyocytes, and highlight the potential therapeutic benefits that could be gained by unraveling the secrets of the inflammatory response.
